Iodine → 1-Benzhydryl-5-iodo-pyrimidine-2,4-dione
反応式
[I:1][C:2]1[C:3](=[O:9])[NH:4][C:5](=[O:8])[NH:6][CH:7]=1.C/C(/O[Si](C)(C)C)=N\[Si](C)(C)C.Br[CH:23]([C:30]1[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1)[C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1.II>CC#N>[CH:23]([N:6]1[CH:7]=[C:2]([I:1])[C:3](=[O:9])[NH:4][C:5]1=[O:8])([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)[C:30]1[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1参加物
反応条件
- 温度
- 84 °C
実験手順
5-Iodouracil (0.10 g, 0.42 mmol) was suspended in dry MeCN (2.1 mL) and N,O-bis(trimethylsilyl)acetamide (0.25 mL, 1.05 mmol) was added under nitrogen atmosphere. When the reaction mixture turned clear, bromodiphenyl methane (0.15 g, 0.63 mmol) and a catalytic amount of I2 were added and the reaction mixture was heated at 84° C. for 4 hrs. After cooling to room temperature, the mixture was concentrated under reduced pressure, diluted with EtOAc and washed with water. The aqueous phase was extracted with EtOAc (3×15 mL), the combined organic layers were washed with brine, dried over Na2SO4 and the solvent was removed under reduced pressure. The crude was purified by column chromatography using a Teledyne ISCO apparatus (cyclohexane:EtOAc 60:40) to afford the title compound (0.15 g, 87%) as white solid. 1H NMR (400 MHz, CDCl3): δ 7.02 (s, 1H), 7.14-7.18 (m, 4H), 7.38-7.45 (m, 6H), 7.46 (s, 1H), 8.58 (s, 1H). MS (ESI) in/Z: 405 [M-H]+.
後処理
- temperatureAfter cooling to room temperature
- concentrationthe mixture was concentrated under reduced pressure
- additiondiluted with EtOAc
- washwashed with water
- extractionThe aqueous phase was extracted with EtOAc (3×15 mL)
- washthe combined organic layers were washed with brine
- dry with materialdried over Na2SO4
- customthe solvent was removed under reduced pressure
- customThe crude was purified by column chromatography
出典と根拠
- ORDレコード
- ord-f3e249ab0ca94a429568bf5e4d26a8ff
- 出典データセット
- uspto-grants-2016_08
- 特許番号
- US09428465B2
反応ノート
読み込み中…